SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : VVUS: VIVUS INC. (NASDAQ)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Nick Prezioso who wrote (11034)7/9/1998 8:41:00 PM
From: VLAD  Read Replies (1) of 23519
 
Nick,

If you can not think of any positives for the future of Vivus then I suggest you take a short position and see if it becomes profitable.

Vasomax is basically worthless and will be only a psycogenic cure.

Harvard Scienticic has nothing to offer except nice press releases.

There is nothing else significant which will hit the market over the next year or two.

I do not know the specifics between Astra and Merks latest agreement.

I do know that Astra is looking for new products and aquisitions but I do not know if the agreement with Merck prevents them from making a domestic aquisition.

In my communications with Astra they have said repeatedly that they are confident that they will sell MUSE profitably and will use the safety and local effect aspects as their marketing strengths.

MUSE was never intended to be used by probably at least 1/2 of those now on Viagra. The real question is what kind of results men with moderate to severe organic ED are getting and how long it will take the failures to seek alternative treatments. I believe many of the failures will eventually trickle into the doctor's office for MUSE or needle therapy. As Edderd pointed out it will take time for this to occur but it will eventually happen.

Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News